RCKT vs TNYA
RCKT: Rocket Pharmaceuticals is a commercial-stage biotech company developing AAV-based gene therapies for rare cardiovascular conditions and genetic disorders. TNYA: Tenaya Therapeutics is a clinical-stage precision medicine company developing curative, genetically-driven therapies to treat the root causes of heart disease.
Side-by-side fundamentals
| Metric | RCKT | TNYA | Edge |
|---|---|---|---|
| Price as of 2026-10-20 close | $2.34 | $0.41 | |
| Market cap | $257M | $92M | |
| ROE FY2025, SEC XBRL | -80.5% | -73.5% | TNYA higher |
| ROA FY2025, SEC XBRL | -67.5% | -61.7% | TNYA higher |
| Dividend streak (yrs) SEC XBRL | 0 | 0 | Tie |
| Beta as of 2026-09-02 | 1.59 | 1.79 | |
| 1-year return as of 2026-10-20 close | -41.5% | -79.2% | RCKT higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-02 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-20.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.